A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines (NCT06671483)
A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001)
🩺 Plain-English Summary (8th-Grade Level)
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA who have not previously been treated with biologic disease-modifying antirheumatic drugs. The participants will be treated with either zasocitinib, active comparator, or placebo. Participants will be in the study for up to 60 weeks.
Who can join: Review the eligibility criteria below.
Location: AARR- Chandler AZ — Chandler, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (188 Sites)
Showing the first 25 of 188 sites.
- AARR- Chandler AZ — Chandler, Arizona
- Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ — Phoenix, Arizona
- Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ — Phoenix, Arizona
- Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ — Phoenix, Arizona
- First OC Dermatology Research Inc. — Fountain Valley, California
- Purushotham & Akther Kotha MD — La Mesa, California
- Triwest Research Associates LLC — La Mesa, California
- The Cohen Medical Centers — Thousand Oaks, California
- Foothill Arthritis Clinic — Tujunga, California
- Medvin Clinical Research — Whittier, California
- Denver Arthritis Clinic | Denver, CO — Denver, Colorado
- Arthritis & Rheumatic Disease Specialties (AARDS) — Aventura, Florida
- RASF- Clinical Research Center — Boca Raton, Florida
- Clinical Research of West Florida | Clearwater, FL — Clearwater, Florida
- GNP Research, LLC | Hollywood, FL — Cooper City, Florida
- Driven Research LLC — Coral Gables, Florida
- Tectum Medical Research — Davie, Florida
- Sweet Hope Research Specialty, Inc, d/b/a Neoclinical Research — Hialeah, Florida
- Bioresearch Partners — Miami, Florida
- HMD Research LLC — Orlando, Florida
- Millennium Research | Ormond Beach, FL — Ormond Beach, Florida
- IRIS Research and Development | Plantation, FL — Plantation, Florida
- Sarasota Arthritis Research Center — Sarasota, Florida
- West Broward Rheumatology Associates, Inc. — Tamarac, Florida
- Clinical Research of West Florida | Tampa, FL — Tampa, Florida
📞 Contact the Study Coordinator
Phone: (877) 825-3327
Email: medinfoUS@takeda.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Psoriatic Arthritis
- A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs — Gilbert, Arizona
- Psoriatic Arthritis D2P Screening — Philadelphia, Pennsylvania
- Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis — Dothan, Alabama
- Apremilast Pregnancy Exposure Registry — La Jolla, California
- Psorcast Mobile Study — Seattle, Washington
- A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy — Anniston, Alabama
Explore by condition: All Psoriatic Arthritis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.